Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07459426) titled 'Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study)' on Feb. 28.

Study Type: Observational

Primary Sponsor: Yasar Bayindir, MD

Condition: Hepatitis B, Chronic

Intervention: Diagnostic Test: Viral genetic material from blood samples using advanced sequencing technology

Recruitment Status: Not recruiting

Date of First Enrollment: March 15, 2026

Target Sample Size: 700

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07459426

Published by HT Digital Content Services with permission from Health Daily Digest....